| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jun―22 |
Allosteric targeting of the ACE2 dimer interface by a medium-sized compound inhibits SARS-CoV-2 entry |
Mariko Yokogawa, Shunki Kaneichi, Mahoro Horiuchi, Taiga Otake, Tomoki Yonezawa, Yugo Shimizu, Kazuyoshi Ikeda, Yuichiro Yamamoto, Shota Sakai, Yoshimi Shimizu, Kohji Noguchi, Masayoshi Fukasawa, Mitsuhiko Ikura, Masanori Osawa |
| 2 |
[GO] |
2026―Jan―10 |
CovInter 2.0: comprehensive molecular interactome of coronavirus infection |
Weimin Lu, Yintao Zhang, Kuerbannisha Amahong, Sisi Zhu, Xiuwen Li, Ying Zhou, Feng Zhu, Lin Tao |
| 3 |
[GO] |
2025―Okt―29 |
RNA Structural Ensemble Determinants of -1 Programmed Ribosomal Frameshifting Efficiency Across Coronavirus Evolution |
Scott R. Allen, Tamar Schlick, Alain Laederach |
| 4 |
[GO] |
2025―Sep―11 |
Exploring the role of structural and dynamic complexity in SARS-CoV-2 Nucleocapsid protein-heparin interactions by NMR |
Tessa Bolognesi, Marco Schiavina, Cristina Ciabini, Michela Parafioriti, Cristina Gardini, Stefano Elli, Marco Guerrini, Roberta Pierattelli, Isabella C. Felli |
| 5 |
[GO] |
2025―Aug―20 |
The C-terminal domain of SARS-CoV-2 nsp8 is a molten globule in the absence of binding partners |
Vilius Kurauskas, Marco Tonelli, Robert N. Kirchdoerfer, Katherine Henzler-Wildman |
| 6 |
[GO] |
2025―Aug―05 |
Structural Dynamics of SARS-CoV-2 NSP4 C-Terminal Domain and Implications for Viral Processing |
Lingshen Meng, Shangxiang Ye, Kai Pei, Chun Tang |
| 7 |
[GO] |
2025―Aug―05 |
From Science to Fiction - connecting in vivo and in vitro results in polyprotein processing of coronaviruses |
Kira Schamoni-Kast, Charlotte Uetrecht |
| 8 |
[GO] |
2025―Jul―02 |
Chaperone Activity of SARS-CoV-2 Nucleocapsid Protein: RNA Annealing and Destabilization Mechanisms |
L. Loussine Zargarian, Xia Ai, Ze-Yu Song, Lara Perez-Gorgol, Esteban Couprie-Diaz, Philippe Fossé, Xu-Guang Xi, Olivier Mauffret |
| 9 |
[GO] |
2025―Mai―28 |
Allostery links hACE2 binding, pan-variant neutralization and helical extension in the SARS-CoV-2 Spike protein |
Alice Colyer, Esther Wolf, Cristina Lento, Mart Ustav Jr., Adnan Sljoka, Derek J. Wilson |
| 10 |
[GO] |
2025―Mrz―18 |
Distinct roles of SARS-CoV-2 N protein and NFP in host cell response modulation |
Hsin-Chi Lan, Bo-Yi Hou, Shu-Ting Chang, Cheng-Yu Kuo, Wei-Chen Wang, Ya-Li Yao, Hung-Yi Wu, Chien-Chen Lai, Wen-Ming Yang |
| 11 |
[GO] |
2024―Sep―06 |
Structural basis of main proteases of coronavirus bound to Bofutrelvir |
Wei-wei Wang, Pei Zeng, Tongchao Liu, Xue-lan Zhou, Cheng Lin, Li Guo, Qi-sheng Wang, Jian Li |
| 12 |
[GO] |
2024―Jul―22 |
Computational Analysis of the accumulation of mutations in therapeutically important RNA viral proteins during pandemics with special emphasis on SARS-CoV-2 |
Abhishek Sharma, CR Chandrashekar, Sudhir Krishna, Ramanathan Sowdhamini |
| 13 |
[GO] |
2024―Mai―16 |
Visualizing the active site oxyanion loop transition upon ensitrelvir binding and transient dimerization of SARS-CoV-2 main protease |
Andrey Kovalevsky, Annie Aniana, Leighton Coates, Rodolfo Ghirlando, Nashaat T. Nashed, John M. Louis |
| 14 |
[GO] |
2023―Jun―23 |
Free Energy Perturbation Calculations of Mutation Effects on SARS-CoV-2 RBD::ACE2 Binding Affinity |
Alina P. Sergeeva, Phinikoula S. Katsamba, Junzhuo Liao, Jared M. Sampson, Fabiana Bahna, Seetha Mannepalli, Nicholas C. Morano, Lawrence Shapiro, Richard A. Friesner, Barry Honig |
| 15 |
[GO] |
2023―Jun―16 |
Validation of X-ray Crystal Structure Ensemble Representations of SARS-CoV-2 Main Protease by Solution NMR Residual Dipolar Couplings |
Yang Shen, Angus J. Robertson, Ad Bax |
| 16 |
[GO] |
2023―Jun―03 |
The RNA interference effector protein Argonaute 2 functions as a restriction factor against SARS-CoV-2 |
Joaquin Lopez-Orozco, Nawell Fayad, Juveriya Qamar Khan, Alberto Felix-Lopez, Mohamed Elaish, Megha Rohamare, Maansi Sharma, Darryl Falzarano, Jerry Pelletier, Joyce Wilson, Tom C. Hobman, Anil Kumar |
| 17 |
[GO] |
2023―Feb―10 |
Selenoprotein S interacts with the replication and transcription complex of SARS-CoV-2 by binding nsp7 |
Farid Ghelichkhani, Fabio A. Gonzalez, Mariia A. Kapitonova data acquisition, Sharon Rozovsky |
| 18 |
[GO] |
2023―Jan―20 |
The Cytoplasmic Domain of the SARS-CoV-2 Envelope Protein Assembles into a β-Sheet Bundle in Lipid Bilayers |
Aurelio J. Dregni, Matthew J. McKay, Wahyu Surya, Maria Queralt-Martin, Joao Medeiros-Silva, Harrison K. Wang, Vicente Aguilella, Jaume Torres, Mei Hong |
| 19 |
[GO] |
2023―Jan―20 |
Fidelity of Ribonucleotide Incorporation by the SARS-CoV-2 Replication Complex |
Xingyu Yin, Horia Popa, Anthony Stapon, Emilie Bouda, Miguel Garcia-Diaz |
| 20 |
[GO] |
2022―Dez―21 |
Variations within the glycan shield of SARS-CoV-2 impact viral spike dynamics |
Maddy L. Newby, Carl A. Fogarty, Joel D. Allen, John Butler, Elisa Fadda, Max Crispin |
| 21 |
[GO] |
2022―Nov―24 |
Human 14-3-3 proteins site-selectively bind the mutational hotspot region of SARS-CoV-2 nucleoprotein modulating its phosphoregulation |
Kristina V. Tugaeva, Andrey A. Sysoev, Anna A. Kapitonova, Jake L. R. Smith, Phillip Zhu, Richard B. Cooley, Alfred A. Antson, Nikolai N. Sluchanko |
| 22 |
[GO] |
2022―Nov―02 |
Unmasking the conformational stability and inhibitor binding to SARS-CoV-2 main protease active site mutants and miniprecursor |
Andrey Kovalevsky, Leighton Coates, Daniel W. Kneller, Rodolfo Ghirlando, Annie Aniana, Nashaat T. Nashed, John M. Louis |
| 23 |
[GO] |
2022―Aug―19 |
Biochemical Characterization of Emerging SARS-CoV-2 Nsp15 Endoribonuclease Variants |
Isha M. Wilson, Meredith N. Frazier, Jian-Liang Li, Thomas A. Randall, Robin E. Stanley |
| 24 |
[GO] |
2022―Jul―16 |
Allosteric hotspots in the main protease of SARS-CoV-2 |
Léonie Strömich, Nan Wu, Mauricio Barahona, Sophia N. Yaliraki |
| 25 |
[GO] |
2022―Jul―15 |
Binding adaptation of GS-441524 diversifies macro domains and downregulate SARS-CoV-2 de-MARylation capacity |
Aikaterini C. Tsika, Angelo Gallo, Nikolaos K. Fourkiotis, Aikaterini I. Argyriou, Sridhar Sreeramulu, Frank Löhr, Vladimir V. Rogov, Christian Richter, Verena Linhard, Santosh L. Gande, Nadide Altincekic, Robin Krishnathas, Isam Elamri, Harald Schwalbe, Jan Wollenhaupt, Manfred S. Weiss, Georgios A. Spyroulias |
| 26 |
[GO] |
2022―Jul―07 |
Structural Basis of Main Proteases of Coronavirus Bound to Drug Candidate PF-07304814 |
Jian Li, Cheng Lin, Xuelan Zhou, Fanglin Zhong, Pei Zeng, Peter J. McCormick, Haihai Jiang, Jin Zhang |
| 27 |
[GO] |
2022―Jun―11 |
Can machines learn the mutation signatures of SARS-CoV-2 and enable viral-genotype guided predictive prognosis? |
Sunil Nagpal, Nishal Kumar Pinna, Namrata Pant, Rohan Singh, Divyanshu Srivastava, Sharmila S. Mande |
| 28 |
[GO] |
2022―Mai―17 |
An electrostatically-steered conformational selection mechanism promotes SARS-CoV-2 Spike protein variation |
Marija Sorokina, Jaydeep Belapure, Christian Tüting, Reinhard Paschke, Ioannis Papasotiriou, João Pglm Rodrigues, Panagiotis L. Kastritis |
| 29 |
[GO] |
2022―Mai―07 |
Biophysical fitness landscape of the SARS-CoV-2 Delta variant receptor binding domain |
Casey Patrick, Vaibhav Upadhyay, Alexandra Lucas, Krishna M.G. Mallela |
| 30 |
[GO] |
2022―Apr―09 |
Development of monoclonal antibodies to detect for SARS-CoV-2 proteins |
Nawneet Mishra, Joan Teyra, Ruthmabel Boytz, Shane Miersch, Trudy N. Merritt, Lia Cardarelli, Maryna Gorelik, Filip Mihalic, Per Jemth, Robert Davey, Sachdev S. Sidhu, Daisy W. Leung, Gaya K. Amarasinghe |
| 31 |
[GO] |
2022―Feb―28 |
SARS-CoV-2 nucleocapsid protein targets a conserved surface groove of the NTF2-like domain of G3BP1 |
Mahamaya Biswal, Jiuwei Lu, Jikui Song |
| 32 |
[GO] |
2022―Jan―03 |
Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development |
Xuesen Zhao, Danying Chen, Xinglin Li, Lauren Griffith, Jinhong Chang, Ping An, Ju-Tao Guo |
| 33 |
[GO] |
2021―Dez―13 |
Where all the roads meet? A crossover prespective on host factors regulating SARS-CoV-2 infection |
Sneh Lata, Ritu Mishra, Ravi P. Arya, Pooja Arora, Anismrita Lahon, Akhil C. Banerjea, Vikas Sood |
| 34 |
[GO] |
2021―Nov―12 |
Disulfide bonds play a critical role in the structure and function of the receptor-binding domain of the SARS-CoV-2 Spike antigen |
Andrey M. Grishin, Nataliya V. Dolgova, Shelby Landreth, Olivier Fisette, Ingrid J. Pickering, Graham N. George, Darryl Falzarano, Miroslaw Cygler |
| 35 |
[GO] |
2021―Okt―28 |
Allosteric regulation of 3CL protease of SARS-CoV-2 and SARS-CoV observed in the crystal structure ensemble |
Akinori Kidera, Kei Moritsugu, Toru Ekimoto, Mitsunori Ikeguchi |
| 36 |
[GO] |
2021―Okt―28 |
Glycosylation and serological reactivity of an expression-enhanced SARS-CoV-2 viral spike mimetic |
Himanshi Chawla, Sian E. Jossi, Sian E. Faustini, Firdaus Samsudin, Joel D. Allen, Yasunori Watanabe, Maddy L. Newby, Edith Marcial-Juárez, Rachel E. Lamerton, Jason S. McLellan, Peter J. Bond, Alex G. Richter, Adam F. Cunningham, Max Crispin |
| 37 |
[GO] |
2021―Okt―01 |
The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation |
Maaran Michael Rajah, Annie Bernier, Julian Buchrieser, Olivier Schwartz |
| 38 |
[GO] |
2021―Sep―22 |
Mechanisms of Antiviral Immune Evasion of SARS-CoV-2 |
Daniel K Beyer, Adriana Forero |
| 39 |
[GO] |
2021―Sep―03 |
Inhibition of SARS-CoV-2 infection by human defensin HNP1 and retrocyclin RC-101 |
Elena Kudryashova, Ashley Zani, Geraldine Vilmen, Amit Sharma, Wuyuan Lu, Jacob S. Yount, Dmitri S. Kudryashov |
| 40 |
[GO] |
2021―Aug―23 |
An Adverse OutcomesApproach to Study theEffects of SARS-CoV-2 in 3D Organoid Models |
Amrita Basu, Annapurna Pamreddy, Pragya Singh, Kumar Sharma |
| 41 |
[GO] |
2021―Jul―28 |
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations |
Shane Miersch, Zhijie Li, Reza Saberianfar, Mart Ustav, James Brett Case, Levi Blazer, Chao Chen, Wei Ye, Alevtina Pavlenco, Maryna Gorelik, Julia Garcia Perez, Suryasree Subramania, Serena Singh, Lynda Ploder, Safder Ganaie, Rita E. Chen, Daisy W. Leung, Pier Paolo Pandolfi, Giuseppe Novelli, Giulia Matusali, Francesca Colavita, Maria R. Capobianchi, Suresh Jain, J.B. Gupta, Gaya K. Amarasinghe, Michael S. Diamond, James Rini, Sachdev S. Sidhu |
| 42 |
[GO] |
2021―Jul―14 |
Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies |
Jiahui Chen, Kaifu Gao, Rui Wang, Guo-Wei Wei |
| 43 |
[GO] |
2021―Jun―24 |
A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process |
G.D. Noske, A.M. Nakamura, V.O. Gawriljuk, R.S. Fernandes, G. M. A. Lima, H. V. D. Rosa, H.D. Pereira, A. C. M. Zeri, A. A. F. Z. Nascimento, M. C. L. C. Freire, D. Fearon, A. Douangamath, F. von Delft, G. Oliva, A.S. Godoy |
| 44 |
[GO] |
2021―Jun―20 |
The inherent dynamics and interaction sites of the SARS-CoV-2 nucleocapsid N-terminal region |
Jasmina S. Redzic, Eunjeong Lee, Alexandra Born, Aaron Issaian, Morkos A. Henen, Parker Nichols, Ashley Blue, Kirk C. Hansen, Angelo D'Alessandro, Beat Vögeli, Elan Zohar Eisenmesser |
| 45 |
[GO] |
2021―Jun―09 |
Can we AlphaFold our way out of the next pandemic? |
Matthew K. Higgins |
| 46 |
[GO] |
2021―Mai―21 |
Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants |
Charlie Laffeber, Kelly de Koning, Roland Kanaar, Joyce HG Lebbink |
| 47 |
[GO] |
2021―Mai―14 |
Structural modeling of the SARS-CoV-2 Spike/human ACE2 complex interface can identify high-affinity variants associated with increased transmissibility |
Hin Hark Gan, Alan Twaddle, Benoit Marchand, Kristin C. Gunsalus |
| 48 |
[GO] |
2021―Apr―22 |
N-Terminal finger stabilizes the S1 pocket for the reversible feline drug GC376 in the SARS-CoV-2 Mpro dimer |
Elena Arutyunova, Muhammad Bashir Khan, Conrad Fischer, Jimmy Lu, Tess Lamer, Wayne Vuong, Marco J. van Belkum, Ryan T. McKay, D. Lorne Tyrrell, John C. Vederas, Howard S. Young, M. Joanne Lemieux |
| 49 |
[GO] |
2021―Apr―08 |
Structure-Based Design of a Specific, Homogeneous Luminescence Enzyme Reporter Assay for SARS-CoV-2 |
Frederic A. Fellouse, Shane Miersch, Chao Chen, Stephen W. Michnick |
| 50 |
[GO] |
2021―Mrz―26 |
Engineered ultra-high affinity synthetic antibodies for SARS-CoV-2 neutralization and detection |
Tomasz Slezak, Anthony A. Kossiakoff |
| 51 |
[GO] |
2021―Mrz―20 |
Platforms for Personalized Polytherapeutics Discovery in COVID-19 |
Chris Hopkins, Chidinma Onweni, Victoria Zambito, DeLisa Fairweather, Kathryn McCormick, Ebihara Hideki, Tom Caulfield, Yu Shrike Zhang, W David Freeman |
| 52 |
[GO] |
2021―Mrz―19 |
SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca2+ |
Alex L. Lai, Jack H. Freed |
| 53 |
[GO] |
2021―Feb―05 |
The mechanism of SARS-CoV-2 nucleocapsid protein recognition by the human 14-3-3 proteins |
Kristina V. Tugaeva, Dorothy E. D. P. Hawkins, Jake L. R. Smith, Oliver W. Bayfield, De-Sheng Ker, Andrey A. Sysoev, Oleg I. Klychnikov, Alfred A. Antson, Nikolai N. Sluchanko |
| 54 |
[GO] |
2020―Dez―17 |
Subtle influence of ACE2 glycan processing on SARS-CoV-2 recognition |
Joel D. Allen, Yasunori Watanabe, Himanshi Chawla, Maddy L. Newby, Max Crispin |
| 55 |
[GO] |
2020―Dez―11 |
The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition |
Takamitsu Hattori, Akiko Koide, Maria G. Noval, Tatyana Panchenko, Larizbeth A. Romero, Kai Wen Teng, Takuya Tada, Nathaniel R. Landau, Kenneth A. Stapleford, Shohei Koide |
| 56 |
[GO] |
2020―Nov―24 |
Structural insights into SARS-CoV-2 proteins |
Rimanshee Arya, Shweta Kumari, Bharati Pandey, Hiral Mistry, Subhash C Bihani, Amit Das, Vishal Prashar, Gagan D Gupta, Lata Panicker, Mukesh Kumar |
| 57 |
[GO] |
2020―Sep―11 |
Anti-Frameshifting Ligand Active against SARS Coronavirus-2 Is Resistant to Natural Mutations of the Frameshift-Stimulatory Pseudoknot |
Krishna Neupane, Sneha Munshi, Meng Zhao, Dustin B. Ritchie, Sandaru M. Ileperuma, Michael T. Woodside |
| 58 |
[GO] |
2020―Jul―23 |
Mutations Strengthened SARS-CoV-2 Infectivity |
Jiahui Chen, Rui Wang, Menglun Wang, Guo-Wei Wei |
| 59 |
[GO] |
2020―Apr―19 |
Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop |
Javier A. Jaimes, Nicole M. André, Joshua S. Chappie, Jean K. Millet, Gary R. Whittaker |
|
